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In their Letter to the Editor, Marsman et al. [1] raised
the question of the reproducibility of Lieber–Decarli
(LDC) high-fat diets for the induction of fatty liver in
rats [2]. The data presented in the letter revealed a strik-
ing diﬀerence in gains in body weight between the rats in
Marsman’s study and those in Lieber’s study. The rats
(Wistar, sex unknown, N = 5) reported by Marsman
et al. had gained 98 g after 21 days of the LCD high-
fat diet ad libitum, whereas in Lieber’s study, the rats
(male Sprague–Dawley, N = 22) had gained 173 g. Thus
daily body weight gain in Marsman’s study (4.2 g) was
only half of that in Lieber’study. (8.2 ± 1.1 g), suggest-
ing an improper methodology in liquid diet feeding, de-
spite, as it was claimed, ‘‘following the authors’ exact
methodology”. Furthermore, no caloric intake of the
high-fat diet or the control standard diet were indicated
in Marsman’s letter, while Lieber et al. reported a total
caloric intake of 1767 ± 42 kcal in 3 weeks and
86 ± 1.7 kcal daily and a comparable intake of the stan-
dard diet. Indeed, gains in body weight of rats (4.2 g/
day) in Marsman’s feeding protocol were nearly identi-
cal to those of rats (4.7 ± 0.1 g, N = 12) fed a restricted
high-fat diet (two-thirds of the amount spontaneously
consumed by rats fed ad libitum) described by Lieber
et al. Since dietary restricted rats developed only modest
steatosis compared to panlobular steatosis in rats fed ad
libitum, one may wonder whether the lack of fatty liver
induction in Marsman’s feeding protocol is the result of
a lower caloric intake caused by an insuﬃcient con-
sumption of the high-fat diet, reminiscent of the dietary
restriction protocol in Lieber’s study. Furthermore,Close monitoring of serum HBV DN
most useful in the management of p
q The authors are the developers of the Lieber–Decarli (LDC) high-
fat diet for the induction of fatty liver in rats.body weight gains in either ad libitum or dietary re-
stricted feeding, and associated fatty changes were
reproduced in a later study published in Journal of
Hepatology [3]. It is imperative that Marsman et al.
reassess the liquid diet feeding methodology to ensure
that both caloric intake and gains in body weight are
equivalent to those described by Lieber et al. [2,3]. Until
then it is presumptuous to conclude that the Lieber–
Decarli high-fat diet model is not reproducible for the
pathogenesis of hepatosteatosis in rats.
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We read with interest the study by Zacharakis et al.
[1] regarding the role of serial measurement of HBV
DNA levels in Greek patients with chronic HBeAg()
hepatitis B infection. We agree that serial HBV DNA le-
vel assessment may be crucial in the prediction of the
natural history of HBeAg() patients, indeed, HBV car-
riers who are negative for HBeAg may replicate HBV to
low levels and reactivation of HBV may occur spontane-
ously or as a result of immunosuppression. Similarly,HBsAg negative patients with occult HBV infections
may reactivate in several contexts and such HBsAg neg-
ative patients were also shown to be associated with high
risk of severe liver disease including cirrhosis or hepato-
cellularcarcinoma. We collected data concerning occult
HBV infections studying a group of 26 patients (15
men, mean age 48) suﬀering from cryptogenetic hepati-
tis. Patients remained negative at the time of diagnosis
for HBsAg by three diﬀerent immunoassays (AgHBs
plus, Bio-rad, HBsAg Ultra, bioMerieux, HBsAg Enzy-
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Fig. 1. HBV infection parameters overtime. (A) Liver enzyme levels for all patients and all dates (n = 274), GGT (gamma glutamyl transpeptidase),
ALAT (alanine amino transferase); N: normal, aN: abnormal. (B) Maximal viral load measured by quantitative PCR [2] during the follow-up of each
patient (n = 26). (C) Representation of the follow-up of one of the occult HBV patients considering ALAT level and HBV viral load.
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were tested showing elevation of ALT, GGT or both
in 80% of the cases (Fig. 1A). A high dynamic in viral
loads was observed and may reach 106 or 107 HBV gen-
ome per ml as detected by light cycler PCR as shown on
Fig. 1B and C [2].
Since molecular biology tools are improving it ap-
pears that monitoring of HBV chronic infection may
include HBV DNA levels. It has recently become evi-
dent that HBV may also persist in the form of serolog-
ically silent infections, leading to the concept of occult
infection. Such infection may represent a non-negligible
part of cryptogenetic hepatitis cases whose diagnosis
and clinical spectrum remain unclear. In a recent state-
ment, occult HBV infection has been deﬁned as the
presence of viral DNA in the liver in the absence of
HBsAg but with low titer or even absence of HBV
DNA in serum [3]. Our study as well as the study by
Zacharakis et al., underline the importance of sequen-
tial testing of patients for HBV DNA level, which is
a key for assessing liver disease activity and predicting
the risk of cirrhosis or hepatocellularcarcinoma. It is
also the clue to decide on the possibility of adapted
antiviral treatment in order to prevent HBV reactiva-
tions or transmission of HBV in the transplantation
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